XOMA Declares Quarterly Preferred Stock Dividends
20 juin 2022 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., June 20, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA to Present at H.C. Wainwright Global Investment Conference
17 mai 2022 16h05 HE
|
XOMA Corporation
EMERYVILLE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events
05 mai 2022 07h30 HE
|
XOMA Corporation
Earned a $2 million milestone from Rezolute as it dosed the final patient in a Phase 2 open-label study of RZ358 in patients with congenital hyperinsulinism in early 2022. Rezolute has announced its...
XOMA Declares Quarterly Preferred Stock Dividends
21 mars 2022 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA to Present at Oppenheimer’s 32nd Annual Healthcare Conference
10 mars 2022 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA Reports Full Year 2021 Financial Results and Highlights Recent Operational Events
08 mars 2022 07h30 HE
|
XOMA Corporation
Earned $35 million milestone payment as NIS793 entered Phase 3 clinical study in metastatic pancreatic cancer Received $1.2 million from three milestone payments, two of which were from a single...
XOMA to Present at the 42nd Annual Cowen Health Care Conference
01 mars 2022 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA to Present at Aegis Capital Corp Investor Conference
17 févr. 2022 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...
XOMA Declares Quarterly Preferred Stock Dividends
23 déc. 2021 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., Dec. 23, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to...
XOMA to Present at Upcoming Investor Conferences
21 déc. 2021 07h30 HE
|
XOMA Corporation
EMERYVILLE, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator playing a distinctive role in helping companies achieve their goal of...